Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bohdan P. Harvey is active.

Publication


Featured researches published by Bohdan P. Harvey.


Journal of Immunology | 2006

B Cells Drive Early T Cell Autoimmunity In Vivo prior to Dendritic Cell-Mediated Autoantigen Presentation

Jun Yan; Bohdan P. Harvey; Renelle J. Gee; Mark J. Shlomchik; Mark J. Mamula

Both B cells and dendritic cells (DCs) have been implicated as autoantigen-presenting cells in the activation of self-reactive T cells. However, most self-proteins are ubiquitously and/or developmentally expressed, making it difficult to determine the source and the exposure of autoantigens to APCs in a controlled manner. In this study, we have used an Ig transgenic mouse model to examine the mechanisms by which B cells and other APCs acquire and present lupus autoantigens in vivo. Targeting a lupus autoantigen, the small nuclear ribonucleoprotein particle D protein, to the BCR activates autoreactive T cells in the periphery. Our in vivo studies demonstrate that autoantigen-specific B cells, when present in the repertoire, are the first subset of APCs to capture and present self-proteins for activating T cells. Thereafter, DCs acquire self-Ag and become effective APCs for stimulating the same subsets of autoreactive T cells. This mechanism provides one explanation of how early steps in autoimmunity can focus responses, via BCR, at a small group of self-proteins among the total milieu of intracellular self-proteins. Subsequently, DCs and other professional APCs may then amplify and perpetuate the autoimmune T cell response.


Journal of Immunology | 2007

Epigenetic and transcriptional programs lead to default IFN-γ production by γδ T cells

Liang Chen; Weifeng He; Sean T. Kim; Jian Tao; Yunfei Gao; Hongbo Chi; Andrew M. Intlekofer; Bohdan P. Harvey; Steven L. Reiner; Zhinan Yin; Richard A. Flavell; Joe Craft

γδ T cells have unique features and functions compared with αβ T cells and have been proposed to bridge the innate and adaptive immune responses. Our earlier studies demonstrated that splenic γδ T cells predominantly produce IFN-γ upon activation in vitro, which is partially due to the expression of the Th1-specific transcription factor T-bet. In this study we have explored the epigenetic and transcriptional programs that underlie default IFN-γ production by γδ T cells. We show that the kinetics of IFN-γ transcription is faster in γδ T cells compared with CD4+ and CD8+ T cells and that γδ T cells produce significantly greater amounts of IFN-γ in a proliferation-independent manner when compared with other T cell subsets. By analyzing the methylation pattern of intron 1 of the ifn-γ locus, we demonstrate that this region in naive γδ T cells is hypomethylated relative to the same element in naive CD4+ and CD8+ T cells. Furthermore, naive γδ T cells constitutively express eomesodermin (Eomes), a transcription factor important for IFN-γ production in CD8+ T cells, and Eomes expression levels are enhanced upon activation. Retroviral transduction of activated γδ T cells from both wild-type and T-bet-deficient mice with a dominant negative form of Eomes significantly reduced IFN-γ production, indicating a critical role for this transcription factor in mediating IFN-γ production by γδ T cells in a T-bet-independent manner. Our results demonstrate that both epigenetic and transcriptional programs contribute to the early vigorous IFN-γ production by γδ T cells.


Journal of Biological Chemistry | 2006

Isoaspartyl Post-translational Modification Triggers Anti-tumor T and B Lymphocyte Immunity

Hester A. Doyle; Jing Zhou; Martin J. Wolff; Bohdan P. Harvey; Robert M. Roman; Renelle J. Gee; Raymond A. Koski; Mark J. Mamula

A hallmark of the immune system is the ability to ignore self-antigens. In attempts to bypass normal immune tolerance, a post-translational protein modification was introduced into self-antigens to break T and B cell tolerance. We demonstrate that immune tolerance is bypassed by immunization with a post-translationally modified melanoma antigen. In particular, the conversion of an aspartic acid to an isoaspartic acid within the melanoma antigen tyrosinase-related protein (TRP)-2 peptide-(181-188) makes the otherwise immunologically ignored TRP-2 antigen immunogenic. Tetramer analysis of iso-Asp TRP-2 peptide-immunized mice demonstrated that CD8+ T cells not only recognized the isoaspartyl TRP-2 peptide but also the native TRP-2 peptide. These CD8+ T cells functioned as cytotoxic T lymphocytes, as they effectively lysed TRP-2 peptide-pulsed targets both in vitro and in vivo. Potentially, post-translational protein modification can be utilized to trigger strong immune responses to either tumor proteins or potentially weakly immunogenic pathogens.


Journal of Immunology | 2008

Editing Antigen Presentation: Antigen Transfer between Human B Lymphocytes and Macrophages Mediated by Class A Scavenger Receptors

Bohdan P. Harvey; Timothy E. Quan; Benjamin Rudenga; Robert M. Roman; Joe Craft; Mark J. Mamula

B lymphocytes can function independently as efficient APCs. However, our previous studies demonstrate that both dendritic cells and macrophages are necessary to propagate immune responses initiated by B cell APCs. This finding led us to identify a process in mice whereby Ag-specific B cells transfer Ag to other APCs. In this study, we report the ability and mechanism by which human B lymphocytes can transfer BCR-captured Ag to macrophages. The transfer of Ag involves direct contact between the two cells followed by the capture of B cell-derived membrane and/or intracellular components by the macrophage. These events are abrogated by blocking scavenger receptor A, a receptor involved in the exchange of membrane between APCs. Macrophages acquire greater amounts of Ag in the presence of specific B cells than in their absence. This mechanism allows B cells to amplify or edit the immune response to specific Ag by transferring BCR-captured Ag to other professional APCs, thereby increasing the frequency of its presentation. Ag transfer may perpetuate chronic autoimmune responses to specific self-proteins and help explain the efficacy of B cell-directed therapies in human disease.


Molecular Immunology | 2014

Transfer of antigen from human B cells to dendritic cells

Bohdan P. Harvey; Maurice T. Raycroft; Timothy E. Quan; Benjamin Rudenga; Robert M. Roman; Joe Craft; Mark J. Mamula

The cooperation of B lymphocytes with other antigen presenting cells (APCs) is often necessary in the efficient processing and presentation of antigen. Herein, we describe a mechanism by which B cells physically interact with dendritic cells (DCs) resulting in the transfer of B cell receptor (BCR)-enriched antigen to these APCs. Antigen transfer involves direct contact between the two cells followed by the capture of B cell derived membrane and intracellular components. Strikingly, DCs acquire greater amounts of antigen by transfer from B cells than by endocytosis of free antigen. Blocking scavenger receptor A, a DC surface receptor involved in membrane acquisition, abrogates these events. We propose that antigen transfer from B cells to DCs results in a more focused immunologic response due to the selective editing of Ag by the BCR.


Journal of Biological Chemistry | 2004

Regulation of the multifunctional Ca2+/calmodulin-dependent protein kinase II by the PP2C phosphatase PPM1F in fibroblasts

Bohdan P. Harvey; Satnam S. Banga; Harvey L. Ozer


Archive | 2013

Autoantigen Presentation Vivo prior to Dendritic Cell-Mediated B Cells Drive Early T Cell Autoimmunity In

Mark J. Mamula; Jun Yan; Bohdan P. Harvey; Renelle J. Gee


Archive | 2013

and Macrophages Mediated by Class A Transfer between Human B Lymphocytes Editing Antigen Presentation: Antigen

Robert M. Roman; Joe Craft; Mark J. Mamula; Bohdan P. Harvey; Timothy E. Quan; Benjamin Rudenga


The FASEB Journal | 2008

Scavenger receptor type AI mediates antigen transfer from human B cells to other APCs

Bohdan P. Harvey; Timothy E. Quan; Robert M. Roman; Benjamin Rudenga; Joe Craft; Mark J. Mamula

Collaboration


Dive into the Bohdan P. Harvey's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew M. Intlekofer

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge